Clinical trial
New Diagnosis or Prognosis Biomarkers for Alzheimer's Disease: Biobank of CSF Collected as Part of Differential Diagnosis of Dementia
NCT03621839 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Diagnosis or Prognosis Biomarkers for Alzheimer's Disease: Biobank of CSF Collected as Part of Differential Diagnosis of Dementia
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 12, 2013
- Completion date
- December 31, 2050
- Enrollment
- 50,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.